TriLink's Research Funding Programs

• Up to $5000 per Year in Free TriLink Products
• Targeted towards university research projects, community college laboratories, and high school science teachers who need additional funds for reagents to teach basic science or start fledgling research programs
• ResearchRewards range from $1000 - $5000 and may be renewable, if merited.

• PCR primers for undergraduate research projects
• Modified nucleoside triphosphates
• DNA synthesis reagents
• Fluorescent probes that can be used to teach the specificity of the genetic code

• ResearchRewards can be used to purchase any of our catalog items and may also be used for certain custom products at TriLink's discretion.
• ResearchRewards can be used for up to 24 months after being awarded.
• If you are a high school teacher or an undergraduate researcher, we will be happy to assist you with ideas for teaching projects or review the use of our products in the design of your research project.

If a ResearchReward is granted, you agree that TriLink:

• may publish your name, institution and the general subject area of your proposal on our web site or in promotional literature
• will be credited as sponsors in publications or presentations.
• will receive a summary at the completion of the sponsored work that will be published on our website or in our newsletter. No further information will be made public until you have published the results or patent applications have been filed by your institution.
• will be granted the first right of negotiation to any commercially usable results in our areas of business from the sponsored work.

• Applications can be downloaded from our website or obtained by calling Client Relations at 858-546-0004. Completed applications should be emailed to sales@trilinkbiotech.com or faxed to 858-546-0020.
• A committee of TriLink scientists and executives review all applications. The information describing your research will be held in the strictest confidence.
• Applications may be submitted anytime; awards are funded on January 15th and July 15th of each year. Applications submitted less than two weeks before these dates will be considered at the next review. Applicants will be notified of the review results by January 31st and July 31st.

• 2007
  
• Dr. Dong Wang; Stanford University
  Structural basis of regulation of RNA polymerase II transcription elongation
• Dr. Stephanie Schroeder; Webster University
  PCR Primer Design for Undergraduate Teaching and Research
• 2006
• Dr. Anne Noronha; Concordia University
  Ability of the E. coli repair protein, Ada C, to correct the DNA alkylation product of the leukemia drug, hepsulfam.
• Dr. Gayathri Devi; Duke University
  Targeting Epidermal Growth Factor Receptor (ErbB2) in Inflammatory Breast Cancer Therapy
• Dr. Etienne Leygue and Jimin Guo; University of Manitoba
  Modulation of Estrogen Receptor Mediated Transcription by Targeting of the Steroid RNA Receptor
• 2005
• Dr. Malte Beringer; University of Witten/Herdecke
  Elucidation of the Mechanism of Ribosome Activity
• Dr. Daniel Herschlag; Stanford University
  Solving RNA Folds at Nucleotide Resolution with Multiplexed Radical Resources
• Dr. Rebecca Bellone; University of Tampa
  Studies Regarding Gene Linkages in Appaloosa Horses
• Dr. John L. McKillip; Ball State University
  Real-time Assessment of Regulator and Virulence Gene Expression in Food Pathogens Using Molecular Beacon NASBA
• Dr. Gordon Lutz; Drexel University
• 2004
• Dr. Jennifer Myka; Thomas Moore University / Brescia University
  PCR Primer Design for Undergraduate Teaching and Research
• Dr. Stephanie Schroeder; Webster University
  PCR Primer Design for Undergraduate Teaching and Research
• Dr. Richard Showman; University of South Carolina
  Ribonucleoside Analog Disruption of Mitochondrial Function in Human Blood Borne Pathogens
• 2003
• Dr. Rebecca Terry; University of Tampa
• Peter Strazewski; Universite Claude Bernard Lyon
• 2002
• Dr. Zucai Suo; Ohio State University
  Kinetic, Dynamic, and Structure-Function Relationship Studies of a DNA Lesion Bypass Polymerase Dpo4
• Dr. Timothy Koh; University of Illinois at Chicago
  Role of Small Heat Shock Proteins in Muscle Injury
• Dr. Robert Striker; University of Wisconsin-Madison
  Nucleotide Selectivity of Error Prone RNA Viral Polymerases

If you have developed a new or unusual nucleoside analog we'd like to hear about it!!

If you have a novel or unusual nucleoside analog, or other compound useful for oligonucleotide synthesis (reagents, linkers, etc.) that you would like see offered to the research community, we would be happy to consider licensing your compound.

Commercializing your compound through TriLink:

• will keep you from being overwhelmed by orders and inquiries that are time consuming to fulfill
• allows its use to be explored in a variety of research applications
• helps you to recoup the investment your lab made to synthesize the compound.

TriLink is also interested in learning about new technologies related to oligonucleotide synthesis. We would be happy to receive any non-confidential information available from you or your institution's technology transfer office.

Questions about or information related to licensing opportunities should be sent to TriLink at: info@trilinkbiotech.com (Subject: Licensing) or give us a call at 858-546-0004 and ask for our Business Development Department.